Rangering i aksjer
#33464
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Aksjekurs
$0.5099
Sist synkronisert: 2024-10-15
Handel Anew Medical, Inc. (WENA)
Pris WENA pris med markedsverdi på B
Markedsverdi av Anew Medical, Inc.(WENA)
Markedsverdi: $7.60M
Per August 2026 har Anew Medical, Inc. en markedsverdi på $7.60M. Dette gjør Anew Medical, Inc. til det 33464th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Anew Medical, Inc. fra 2024 til 2026
WENA sammenlignet med topp 5 mest populære stocks
| Pris på WENA |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.452T
|
+71,731,742.10%
|
|
|
|
|
$4.490T
|
+59,076,428.18%
|
|
|
|
|
$4.162T
|
+54,765,924.71%
|
|
|
|
|
$3.676T
|
+48,370,628.76%
|
|
|
|
|
$2.833T
|
+37,275,082.79%
|
